GW Pharmaceuticals
GW Pharmaceuticals Releases a Q4 Revenue Beat, but Will the Rapid Growth Continue?
Bottom Line Cannabinoid prescription medicine company GW Pharmaceuticals (NASDAQ: GWPH) pre-announced revenues for its fourth quarter and full-year last night.…
Britain’s First Cannabis-Based Medicine Will Be Available in January
Epidyolex will be available for British epilepsy sufferers from Jan. 6 after the government fast-tracked it into the National Health…